| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.7M | +9.4% |
| SG&A Expense | $4.4M | -37.4% |
| Operating Income | -$6.2M | +28.8% |
| Net Income | -$6.1M | +23.9% |
| EPS (Basic) | -$0.54 | +31.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $1.6M | +0.4% |
| Total Assets | $2.4M | +28.6% |
| Current Liabilities | $1.4M | -71.8% |
| Total Liabilities | $1.4M | -71.2% |
| Stockholders' Equity | -$3.2M | -5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -94.3% |
| Capital Expenditures | $5K | — |
| Investing Cash Flow | -$5K | — |
| Financing Cash Flow | $5.1M | +77.9% |
| Free Cash Flow | -$5.1M | -94.5% |